Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Prostrate cancer genes nucleic acid amplification test system

Número de PMA: P100033 · 2020-07-21

SolicitanteGen-Probe Incorporated
Fecha de decisión2020-07-21
Número PMAP100033
Código de productoOYM
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorPA

Resumen del dispositivo

Prostrate cancer genes nucleic acid amplification test system is the device name listed in this FDA 510(k) record. The listed applicant is Gen-Probe Incorporated. It received FDA 510(k) clearance on 2020-07-21. The device is classified under product code OYM. It was reviewed by the PA advisory panel.

Preguntas frecuentes

What is the Prostrate cancer genes nucleic acid amplification test system?

Prostrate cancer genes nucleic acid amplification test system is a medical device that received FDA 510(k) clearance on 2020-07-21. The listed applicant is Gen-Probe Incorporated.

When did Prostrate cancer genes nucleic acid amplification test system receive FDA 510(k) clearance?

The clearance date for Prostrate cancer genes nucleic acid amplification test system can be found in the official FDA records.

Who is the listed applicant for Prostrate cancer genes nucleic acid amplification test system?

The FDA 510(k) record lists Gen-Probe Incorporated as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Prostrate cancer genes nucleic acid amplification test system?

The FDA product code for Prostrate cancer genes nucleic acid amplification test system is OYM.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑